$0.950
+0.039 (+4.09%)收盤時
XWEL 資訊
XWEL 事件
Xwell Divests XpresSpa and XpresTest for $13M
Xwell announced that the company has entered into a definitive agreement with an affiliate of Face Haus, Express Wellness Group, under which Xwell will divest its XpresSpa and XpresTest businesses for $13M, subject to certain closing adjustments. The transaction, which is expected to close later in 2026, is subject to Xwell stockholder approval and the satisfaction of other closing conditions.
XWELL CEO Emphasizes Brand Relevance and Market Expansion
"We continue to execute against our strategic priorities by expanding outside of the airport, diversifying access points and elevating brand relevance," said Ezra Ernst, CEO of XWELL. "The opening of our off-airport wellness center in Penn Station and growth across key Florida markets reflects XWELL's ability to extend services beyond the airport and into the everyday lives of our customers. Coupled with our long-standing CDC partnership and ongoing operational discipline, we believe XWELL is well positioned to create long-term value."
Xwell Partners with PieQ for Biosecurity Forecasting Platform
Xwell announced a strategic partnership with AI and predictive intelligence company PieQ to develop a next-generation U.S. biosecurity forecasting platform in support of the Centers for Disease Control and Prevention, CDC. The announcement follows a recent CDC milestone for the Traveler-based Genomic Surveillance, TGS, program - part of the Biothreat Radar Detection System - which has surpassed one million voluntary participants with XWELL and Ginkgo Biosecurity.
XWELL Expands Global Biosecurity Strategy, Appoints Former CDC Advisor as Senior Advisor
XWELL announced the continued expansion of its global biosecurity strategy, leveraging its traveler-based pathogen surveillance capabilities to support international travel hubs and large-scale mass gathering events worldwide. To support this next phase of growth, XWELL announced that Cindy Friedman, M.D., former CDC senior advisor and the founding director of CDC's Traveler-based Genomic Surveillance program, will serve as a senior advisor to the Company. In this role, Dr. Friedman will provide strategic guidance on the design and adaptation of traveler-based surveillance approaches for select international biosecurity initiatives. Building on its U.S. foundation, XWELL is now expanding its biosecurity strategy internationally, focusing on applying proven surveillance models to global travel hubs and large-scale mass gatherings, including major religious and sporting events. The company currently operates wellness and biosecurity programs across seven major U.S. airports and works closely with public health stakeholders in major international travel corridors.
XWELL Opens New Location in New York's Pennsylvania Station
XWELL announces the opening of its newest location inside New York City's Pennsylvania Station. "Our entry into Penn Station marks a natural next step for XWELL as we continue evolving to meet people where they are," said Ezra Ernst, CEO of XWELL. "Wellness shouldn't be reserved for special occasions or hard-to-reach destinations. With this location, we're embedding accessible self-care into one of the busiest places in America-bringing calm, relief and recharge to everyday routines."
本頁僅供研究參考，不構成投資建議。模型可能出錯。過往表現不代表未來結果。